INDEGENE
|
The Current P/E Ratio of INDEGENE is 34.05.
Share Price | ₹576.7 | Jul 15,2025 |
Market Cap | ₹13,846.6 Cr | |
Earnings-TTM | ₹406.7 Cr | TTM-Consolidated Results |
Price/Earnings | 34.05x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of INDEGENE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹13,846.6 Cr] as on Jul 15,2025
(/) Earnings [ ₹406.7 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 34.05x ]
Thus, for INDEGENE , the investors are currently willing to pay 34.05 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of INDEGENE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of INDEGENE over the last five years.
Historical PE (Price/Earnings) ratio chart of INDEGENE
PE Ratio Performance Analysis for INDEGENE
- INDEGENE 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 6.81x.
- INDEGENE 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INDEGENE 's p/e ratio peaked in Mar2025 at 34.05x.
- INDEGENE 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does INDEGENE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
INDEGENE | 406.70 | 34.05 | 13,846.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 37.75 | 414,533.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 82.25 | 180,215.0 |
CIPLA LTD | 5,291.05 | 22.76 | 120,428.0 |
TORRENT PHARMACEUTICALS LTD | 1,911.00 | 60.92 | 116,410.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 18.45 | 105,253.0 |
MANKIND PHARMA LTD | 2,003.22 | 54.64 | 109,464.0 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 21.09 | 97,317.9 |
LUPIN LTD | 3,306.26 | 26.96 | 89,121.3 |
AUROBINDO PHARMA LTD | 3,515.26 | 19.03 | 66,911.2 |
ABBOTT INDIA LTD | 1,414.44 | 51.57 | 72,938.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs INDEGENE 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.45x |
Max industry PE | 82.25x |
Median industry PE | 34.05x |
Average industry PE | 39.04x |
You may also like the below Video Courses